rhoen-klinikum ag - RHKJF

RHKJF

Close Chg Chg %
13.25 2.05 15.47%

Closed Market

15.30

+2.05 (15.47%)

Volume: 249.00

Last Updated:

Jan 13, 2025, 2:23 PM EDT

Company Overview: rhoen-klinikum ag - RHKJF

RHKJF Key Data

Open

$15.30

Day Range

15.30 - 15.30

52 Week Range

N/A - N/A

Market Cap

$1.02B

Shares Outstanding

66.94M

Public Float

3.65M

Beta

-0.03

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

$0.63

Yield

N/A

Dividend

$0.11

EX-DIVIDEND DATE

Jun 4, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

RHKJF Performance

No Data Available

RHKJF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About rhoen-klinikum ag - RHKJF

Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.

RHKJF At a Glance

Rhön-Klinikum AG
Schlossplatz 1
Bad Neustadt an der Saale, Bayern (Bavaria) 97616
Phone 49-9771-65-0 Revenue 1.98B
Industry Hospital/Nursing Management Net Income 46.89M
Sector Health Services 2024 Sales Growth 9.292%
Fiscal Year-end 12 / 2025 Employees 18,744
View SEC Filings

RHKJF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 20.547
Price to Sales Ratio 0.488
Price to Book Ratio 0.718
Price to Cash Flow Ratio 6.42
Enterprise Value to EBITDA 9.055
Enterprise Value to Sales 0.367
Total Debt to Enterprise Value 0.214

RHKJF Efficiency

Revenue/Employee 105,429.012
Income Per Employee 2,501.727
Receivables Turnover 4.256
Total Asset Turnover 1.017

RHKJF Liquidity

Current Ratio 2.233
Quick Ratio 2.141
Cash Ratio 1.011

RHKJF Profitability

Gross Margin 9.349
Operating Margin 0.627
Pretax Margin 3.07
Net Margin 2.373
Return on Assets 2.412
Return on Equity 3.442
Return on Total Capital 3.133
Return on Invested Capital 3.12

RHKJF Capital Structure

Total Debt to Total Equity 11.547
Total Debt to Total Capital 10.352
Total Debt to Total Assets 8.061
Long-Term Debt to Equity 8.874
Long-Term Debt to Total Capital 7.955
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Rhoen-klinikum Ag - RHKJF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.86B 1.71B 1.81B 1.98B
Sales Growth
+6.73% -7.81% +5.43% +9.29%
Cost of Goods Sold (COGS) incl D&A
1.69B 1.55B 1.66B 1.79B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
82.43M 72.03M 70.47M 67.74M
Depreciation
76.40M 66.77M 65.28M 63.09M
Amortization of Intangibles
6.03M 5.25M 5.19M 4.65M
COGS Growth
+4.56% -8.25% +7.34% +7.86%
Gross Income
173.74M 167.71M 147.30M 184.76M
Gross Income Growth
+33.54% -3.47% -12.17% +25.43%
Gross Profit Margin
+9.34% +9.78% +8.15% +9.35%
2021 2022 2023 2024 5-year trend
SG&A Expense
166.67M 146.57M 168.14M 172.16M
Research & Development
- - - -
-
Other SG&A
166.67M 146.57M 168.14M 172.16M
SGA Growth
+10.37% -12.06% +14.72% +2.39%
Other Operating Expense
236.40K 315.29K 216.22K 216.34K
Unusual Expense
(1.71M) 12.25M (2.07M) 4.03M
EBIT after Unusual Expense
8.54M 8.57M (18.99M) 8.36M
Non Operating Income/Expense
27.47M 30.96M 74.56M 55.71M
Non-Operating Interest Income
582.72K 1.35M 11.37M 11.97M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
3.77M 4.28M 3.99M 3.40M
Interest Expense Growth
-55.22% +13.32% -6.74% -14.84%
Gross Interest Expense
3.77M 4.28M 3.99M 3.40M
Interest Capitalized
- - - -
-
Pretax Income
32.24M 35.26M 51.58M 60.68M
Pretax Income Growth
+635.47% +9.38% +46.27% +17.64%
Pretax Margin
+1.73% +2.06% +2.85% +3.07%
Income Tax
(3.39M) 7.03M 8.18M 11.90M
Income Tax - Current - Domestic
(2.80M) 6.29M 7.31M 6.92M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(590.99K) 735.68K 864.89K 4.98M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
35.73M 28.31M 43.43M 48.90M
Minority Interest Expense
2.28M 1.89M 1.57M 2.01M
Net Income
33.44M 26.43M 41.85M 46.89M
Net Income Growth
+1,921.89% -20.99% +58.38% +12.04%
Net Margin Growth
+1.80% +1.54% +2.31% +2.37%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
33.44M 26.43M 41.85M 46.89M
Preferred Dividends
- - - -
-
Net Income Available to Common
33.44M 26.43M 41.85M 46.89M
EPS (Basic)
0.4996 0.3948 0.6252 0.7005
EPS (Basic) Growth
+1,922.67% -20.98% +58.36% +12.04%
Basic Shares Outstanding
66.94M 66.94M 66.94M 66.94M
EPS (Diluted)
0.4996 0.3948 0.6252 0.7005
EPS (Diluted) Growth
+1,922.67% -20.98% +58.36% +12.04%
Diluted Shares Outstanding
66.94M 66.94M 66.94M 66.94M
EBITDA
89.26M 92.85M 49.41M 80.12M
EBITDA Growth
+53.86% +4.02% -46.78% +62.16%
EBITDA Margin
+4.80% +5.41% +2.73% +4.05%

Rhoen-Klinikum Ag in the News